Immunotherapy to reduce frequency of urinary tract infections in people with neurogenic bladder dysfunction; a pilot randomised, placebo-controlled trial

OBJECTIVE: To establish the feasibility of a randomized, placebo-controlled trial to investigate the effect of a specific immunotherapy bacterial lysate OM-89 (Uro-Vaxom(®)) in reducing the frequency of urinary tract infections in people with neurogenic bladder dysfunction. DESIGN: A parallel-group,...

Descripción completa

Detalles Bibliográficos
Autores principales: Wade, Derick T, Cooper, James, Peckham, Nicholas, Belci, Maurizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Evaluative Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649953/
https://www.ncbi.nlm.nih.gov/pubmed/32762340
http://dx.doi.org/10.1177/0269215520946065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649953/
https://www.ncbi.nlm.nih.gov/pubmed/32762340
http://dx.doi.org/10.1177/0269215520946065

Ejemplares similares